Zepbound Prescribing Practices

News

Zepbound beats Wegovy for weight loss

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the rival medicines.

· 3d · on MSN

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

· 2d

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study

13d

CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click ...

NJBIZ13h

Frier Levitt to host webinar on GLP-1 legal risks

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

The New York Times4d

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight ... pharmacy benefit managers and how their business practices impact patients. Tens of thousands of Americans will ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Zepbound beats Wegovy for weight loss

Trending now